Potential Mechanisms for a Proinflammatory Vascular Cytokine Response to Coagulation Activation
1998 · The Journal of Immunology · 209 citations
https://doi.org/10.4049/jimmunol.160.10.5130
K
Kirk W. Johnson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
169
Papers
10.2K
Citations
52
h-index
109
i10-index
Kirk W. Johnson is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Migraine and Headache Studies & Pain Mechanisms and Treatments & Neuropeptides and Animal Physiology. The author has an h-index of 52, co-authored 144 publications.
ORCID: 0000-0003-0849-508XPapers by this author
worksPreclinical pharmacological profile of the selective 5-HT<sub>1F</sub>receptor agonist lasmiditan
2010 · Cephalalgia · 207 citations
https://doi.org/10.1177/0333102410370873
Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
2020 · Pain · 89 citations
https://doi.org/10.1097/j.pain.0000000000001801
Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo
2006 · Journal of Pharmacology and Experimental Therapeutics · 74 citations
https://doi.org/10.1124/jpet.106.101428
Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses
2008 · British Journal of Clinical Pharmacology · 71 citations
https://doi.org/10.1111/j.1365-2125.2008.03270.x
Ethyl (3<i>S</i>,4a<i>R</i>,6<i>S</i>,8a<i>R</i>)-6-(4-Ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic Ester: A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Models of Acute Migraine
2002 · Journal of Medicinal Chemistry · 51 citations
https://doi.org/10.1021/jm025548q
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat